Cytidine monophosphate (CMP)-N-acetylneuraminate-alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase
RxNorm 21334
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 21334 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Cytidine monophosphate (CMP)-N-acetylneuraminate-alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
CMP-N-acetylneuraminate-alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase
(Atom ID: 400337)
SY
Synonym (SY):
Cytidine monophosphate (CMP)-N-acetylneuraminate-alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase
(Atom ID: 2545304)
SY
Synonym (SY):
Cytidine monophosphate-N-acetylneuraminate-alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase
(Atom ID: 5939455)
FN